Secukinumab Successful in Spondylitis, Psoriatic ArthritisSecukinumab Successful in Spondylitis, Psoriatic Arthritis

The interleukin-17 inhibitor is effective for patients with ankylosing spondylitis, including those who failed on TNF inhibitors, and for patients with psoriatic arthritis, new phase 3 studies show. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news